Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling

Shinji Hirata1, Naoya Takayama, Ryoko Jono-Ohnishi

  • 1Clinical Application Department, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Insights

Congenital amegakaryocytic thrombocytopenia (CAMT) stems from faulty MPL signaling, impacting blood cell development. This study reveals impaired transcriptional regulation of MPL signaling as the root cause of CAMT.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Genetics

Background:

  • Congenital amegakaryocytic thrombocytopenia (CAMT) is a severe bone marrow failure disorder.
  • It results from defective thrombopoietin receptor (MPL)-mediated signaling.
  • Mpl(-/-) mouse models do not fully replicate the human CAMT phenotype.

Purpose of the Study:

  • To investigate the role of MPL signaling in human hematopoiesis using patient-derived induced pluripotent stem cells (iPSCs).
  • To elucidate the mechanisms underlying bone marrow failure in CAMT.

Main Methods:

  • Utilized an in vitro system with iPSCs from a CAMT patient and healthy controls.
  • Analyzed the impact of MPL signaling on hematopoietic progenitor cell populations (CD34+, CD41+, GPA+).
  • Employed retroviral transduction to overexpress MPL in iPSC-derived hematopoietic progenitor cells (HPCs).

Main Results:

  • MPL signaling is crucial for maintaining multipotent hematopoietic progenitor (MPP) and megakaryocyte-erythrocyte progenitor (MEP) populations.
  • MPL signaling influences the differentiation fate towards megakaryopoiesis and erythropoiesis differently in normal versus CAMT cells.
  • MPL overexpression in CAMT iPSC-derived HPCs impaired erythropoiesis and increased aberrant megakaryocyte production, linked to FLI1 expression differences.

Conclusions:

  • Impaired transcriptional regulation of MPL signaling underlies the pathogenesis of CAMT.
  • MPL signaling plays a complex role in regulating megakaryopoiesis and erythropoiesis.
  • FLI1 transcription factor expression is implicated in the aberrant hematopoiesis observed in CAMT.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...